News and Updates

The American Diabetes Association’s (ADA) 79th Scientific Sessions is almost here! From June 7-11, in San Francisco, CA, scientists and healthcare professionals will gather at one of the largest conferences of diabetes researchers in the world. Breakthrough T1D researchers and Breakthrough T1D-funded scientists will also be there to hear first-hand and present new study results […]

On June 4, Breakthrough T1D’s President & CEO Aaron J. Kowalski, Ph.D., testified before the U.S. House of Representatives Committee on Energy & Commerce, Health Subcommittee about Breakthrough T1D’s top legislative priority — securing a long-term renewal of the Special Diabetes Program (SDP) before it expires at the end of September. During the hearing, Dr. […]

The Breakthrough T1D Spring Beta Cell Replacement Consortium meeting, held recently in NYC, allowed 55 researchers from a diversity of destinations and expertise to exhibit beta cell replacement progress in a forum that encourages partnerships and real-time conversations. According to the rotating structure of the meeting, researchers who didn’t present at the meeting expounded upon […]

Hypoglycemia, or low blood sugar, can have serious effects, and it is, for most people with type 1 diabetes (T1D), the most feared complication of this disease. Even before it leads to a coma or seizures, hypoglycemia can carry with it sweatiness (like a panic attack), shaky hands, feeling weak and confusion. Typically, one would […]

Breakthrough T1D’s innovative approach to driving more funds into type 1 diabetes (T1D) medical advances caught the attention of the WSJ, which ran a feature article on how the T1D Fund is leading a growing movement in nonprofits to wield greater influence inside the startup ecosystem. “The kind of education and support these groups can […]

They shared new developments and applauded the speed of scientific advancements. At this year’s Strategic Research Session, the tone was dynamic as Breakthrough T1D’s internal team of scientists, leading type 1 diabetes (T1D) researchers, innovative strategic advisors and volunteers from the T1D community came together to chart the direction of Breakthrough T1D research for the […]

Immune therapy has transformed cancer care. In some cases, cancer is effectively cured in people with stage 4 disease. But it has a catch: In about one percent of people treated with immune therapy, their immune system goes haywire, and it attacks the beta cells in the pancreas, leaving them with type 1 diabetes (T1D) […]

 Breakthrough T1D funds type 1 diabetes (T1D) clinical trials that are critical to bringing new devices and treatments to people with this disease. Currently, there are more than 70 Breakthrough T1D-funded clinical trials, to both prevent and treat this disease and its complications. We hope that, ultimately, these trials will lead to a cure for […]

As many of you know, UnitedHealthcare (UHC) has limited insulin pump choice for children and adults through a new policy called a preferred pump agreement. Breakthrough T1D believes that consumer choice is essential for the T1D community, and that an insurance company should never stand between a patient and doctor. To that end, we have […]

When you have type 1 diabetes (T1D), people might see the CGM on your arm, the pump tubing, or the finger pricks. Some may even see the physical challenge of balancing food, physical activity and insulin. But what only the people who live with T1D see is the internal struggle that comes with living with […]